NewEdge Advisors’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.89K Buy
+50
New +$6.99K ﹤0.01% 3539
2024
Q2
Sell
-54
Closed -$9.93K 3974
2024
Q1
$9.93K Sell
54
-35
-39% -$6.67K ﹤0.01% 2885
2023
Q4
$16K Sell
89
-1,769
-95% -$275K ﹤0.01% 2667
2023
Q3
$295K Buy
1,858
+1,771
+2,036% +$290K ﹤0.01% 1434
2023
Q2
$12.3K Buy
87
+5
+6% +$802 ﹤0.01% 2542
2023
Q1
$13.8K Sell
82
-246
-75% -$43.9K ﹤0.01% 2472
2022
Q4
$34.9K Buy
+328
New +$59.5K ﹤0.01% 1879

Other funds holding RGEN

NewEdge Advisors's RGEN Position: Q1 2026 in Review

NewEdge Advisors opened a new position in Repligen (RGEN) in Q1 2026: 50 shares worth $5.89K. The stake represents ﹤0.01% of the portfolio and ranks #3539 among its holdings. This is a return to the name: NewEdge Advisors previously reported a position in RGEN as recently as Q1 2024.

NewEdge Advisors first reported a position in RGEN in Q4 2022 and has held it in 7 quarters since. The position peaked at $295K in Q3 2023. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • NewEdge Advisors held 50 shares of Repligen worth $5.89K as of Q1 2026.
  • Repligen was a new NewEdge Advisors position in Q1 2026.
  • Repligen made up ﹤0.01% of NewEdge Advisors's portfolio in Q1 2026, its #3539 holding.
  • NewEdge Advisors first reported a position in Repligen in Q4 2022 and has held it in 7 quarters since.
  • NewEdge Advisors's Repligen position peaked at $295K in Q3 2023.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on NewEdge Advisors's 13F filing for Q1 2026, filed 18 May 2026.